![Sandra Calvin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sandra Calvin
Comptroller/Controller/Auditor at
TRAVERE THERAPEUTICS, INC.
Net worth: 2 M $ as of 2026-05-30
Profile
Sandra Calvin is currently Chief Accounting Officer & Senior Vice President at Travere Therapeutics, Inc., a position held since 2014.
Ms. Calvin completed undergraduate studies at San Diego State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-13 | 42,353 ( 0.05% ) | 2 M $ | 2026-05-30 |
Sandra Calvin active positions
| Companies | Position | Start |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2014-11-30 |
Training of Sandra Calvin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
16
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
- Stock Market
- Insiders
- Sandra Calvin
